Inventor
HALENBECK ROBERT F
US33 patents
⚠️ This page may combine multiple inventors who share the name “HALENBECK ROBERT F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CHIRON CORP
19 patentsUS6323326B1Nov 27, 2001
Method of solubilizing, purifying, and refolding protein
CHIRON CORP31 citations93
US5998378ADec 7, 1999
Compositions for the inhibition of TNF hormone formation and uses thereof
CHIRON CORP28 citations91
US6319896B1Nov 20, 2001
Method of solubilizing, purifying, and refolding protein
CHIRON CORP15 citations90
US6204020B1Mar 20, 2001
DNA encoding N∇2 CSF-1 (short form) and carboxy truncated fragment thereof
CHIRON CORP12 citations81
US6117422ASep 12, 2000
N∇2-CSF-1(long form) and carboxy truncated fragments thereof
CHIRON CORP14 citations81
US5965382AOct 12, 1999
Nucleic acid encoding secreted Mac-2 binding glycoprotein
CHIRON CORP13 citations81
US5681719AOct 28, 1997
DNA encoding N- and C- terminally truncated colony stimulating factor-1 variants
CHIRON CORP11 citations81
US5643563AJul 1, 1997
N-∇3 deletion mutants of the short form of CSF-1
CHIRON CORP12 citations81
US6146851ANov 14, 2000
DNA encoding NV2 (long form) and carboxy truncated fragments thereof
CHIRON CORP10 citations73
US6103224AAug 15, 2000
N∇2 CSF-1 (short form) and carboxy truncated fragments thereof
CHIRON CORP11 citations73
US6069127AMay 30, 2000
Secreted mac-2-binding glycoprotein
CHIRON CORP9 citations72
US5644035AJul 1, 1997
Method for purifying secreted Mac-2-binding glycoprotein
CHIRON CORP10 citations72
US7186530B1Mar 6, 2007
Protein associated with cell stress response
CHIRON CORP2 citations63
US5672343ASep 30, 1997
N- 3 deletion mutants of the long form of CSF-1
CHIRON CORP1 citations62
US5843693ADec 1, 1998
Assay method for screening for inhibitors of proTNF conversion
CHIRON CORP3 citations61
US6599706B1Jul 29, 2003
Recombinant PR-3 and assays employing the same
CHIRON CORP3 citations59
US6586222B1Jul 1, 2003
Recombinant PR-3 and compositions thereof
CHIRON CORP1 citations51
US5736340AApr 7, 1998
Secreted Mac-2-binding glycoprotein
CHIRON CORP0 citations51
US6156300ADec 5, 2000
Point mutants of N∇2 CSF-1 and carboxy truncated fragments thereof
CHIRON CORP0 citations41
CETUS CORP
7 patentsUS5116943AMay 26, 1992
Oxidation-resistant muteins of Il-2 and other protein
CETUS CORP230 citations96
US4752585AJun 21, 1988
Oxidation-resistant muteins
CETUS CORP91 citations96
US4572798AFeb 25, 1986
Method for promoting disulfide bond formation in recombinant proteins
CETUS CORP119 citations96
US5104975AApr 14, 1992
Compositions for detecting ras gene proteins and cancer therapeutics
CETUS CORP48 citations95
US4569913AFeb 11, 1986
P. obtusus pyranose-2-oxidase preparation
CETUS CORP9 citations74
US4568645AFeb 4, 1986
Fungal pyranose-2-oxidase preparations
CETUS CORP3 citations63
US4569910AFeb 11, 1986
Methods and reagents for pyranosone production
CETUS CORP4 citations62
CETUS ONCOLOGY CORP
5 patentsUS5206344AApr 27, 1993
Interleukin-2 muteins and polymer conjugation thereof
CETUS ONCOLOGY CORP948 citations96
US5573930ANov 12, 1996
DNA encoding various forms of colony stimulating factor-1
CETUS ONCOLOGY CORP31 citations95
USRE35171EMar 5, 1996
Compositions for detecting ras gene proteins and cancer therapeutics
CETUS ONCOLOGY CORP36 citations91
US5491065AFeb 13, 1996
Monoclonal antibodies that bind to and neutralize dimeric but not monomeric human M-CSF and methods of use thereof for detection of dimeric M-CSF
CETUS ONCOLOGY CORP36 citations89
US5234839AAug 10, 1993
Compositions for detecting ras gene proteins and cancer therapeutics
CETUS ONCOLOGY CORP47 citations89